# FDA Inspection 1122789 - Biomat USA Inc - February 18, 2020

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4dc56444-d7ae-4ec1-b91b-2bf205603cf3
Source feed: FDA_Inspections

> FDA Inspection 1122789 for Biomat USA Inc on February 18, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122789
- Company Name: Biomat USA Inc
- Inspection Date: 2020-02-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1028669 - 2017-08-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/817f6e0b-e795-4f8a-b9e2-a47c74475e1e)
- [FDA Inspection 943172 - 2015-09-04](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9171f8b0-963d-4f42-a068-d7017841cf04)
- [FDA Inspection 836478 - 2013-06-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7f198140-1b1a-46e2-ba3d-289db059de61)

Company: https://www.keypedia.com/companies/biomat-usa-inc/c62d399c-5859-43a9-bad9-4dd50b9d6d8a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d